» Articles » PMID: 11904438

G Protein-coupled Receptor Kinase 4 Gene Variants in Human Essential Hypertension

Abstract

Essential hypertension has a heritability as high as 30-50%, but its genetic cause(s) has not been determined despite intensive investigation. The renal dopaminergic system exerts a pivotal role in maintaining fluid and electrolyte balance and participates in the pathogenesis of genetic hypertension. In genetic hypertension, the ability of dopamine and D(1)-like agonists to increase urinary sodium excretion is impaired. A defective coupling between the D(1) dopamine receptor and the G protein/effector enzyme complex in the proximal tubule of the kidney is the cause of the impaired renal dopaminergic action in genetic rodent and human essential hypertension. We now report that, in human essential hypertension, single nucleotide polymorphisms of a G protein-coupled receptor kinase, GRK4gamma, increase G protein-coupled receptor kinase (GRK) activity and cause the serine phosphorylation and uncoupling of the D(1) receptor from its G protein/effector enzyme complex in the renal proximal tubule and in transfected Chinese hamster ovary cells. Moreover, expressing GRK4gammaA142V but not the wild-type gene in transgenic mice produces hypertension and impairs the diuretic and natriuretic but not the hypotensive effects of D(1)-like agonist stimulation. These findings provide a mechanism for the D(1) receptor coupling defect in the kidney and may explain the inability of the kidney to properly excrete sodium in genetic hypertension.

Citing Articles

Association between parental high-sensitive C-reactive protein and hypertension in offspring: an intergenerational study.

Yang X, Cui F, Chen S, Wang G, Wu S, Cui L Clin Hypertens. 2025; 31:e6.

PMID: 39944935 PMC: 11800284. DOI: 10.5646/ch.2025.31.e6.


An Overview on Renal and Central Regulation of Blood Pressure by Neuropeptide FF and Its Receptors.

Lee H, Feranil J, Jose P Int J Mol Sci. 2025; 25(24.

PMID: 39769048 PMC: 11675822. DOI: 10.3390/ijms252413284.


G protein-coupled receptor kinases in hypertension: physiology, pathogenesis, and therapeutic targets.

Zhang F, Armando I, Jose P, Zeng C, Yang J Hypertens Res. 2024; 47(9):2317-2336.

PMID: 38961282 PMC: 11374685. DOI: 10.1038/s41440-024-01763-y.


Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy.

Duarte J, Thomas C, Lee C, Huddart R, Agundez J, Baye J Clin Pharmacol Ther. 2024; 116(4):939-947.

PMID: 38951961 PMC: 11502236. DOI: 10.1002/cpt.3351.


Quantitative proteomics assay reveals G protein-coupled receptor kinase 4-induced HepG2 cell growth inhibition.

Luo Y, Yang J, Wang Y Heliyon. 2024; 10(8):e29514.

PMID: 38638965 PMC: 11024620. DOI: 10.1016/j.heliyon.2024.e29514.


References
1.
Premont R, MACRAE A, Stoffel R, Chung N, Pitcher J, Ambrose C . Characterization of the G protein-coupled receptor kinase GRK4. Identification of four splice variants. J Biol Chem. 1996; 271(11):6403-10. DOI: 10.1074/jbc.271.11.6403. View

2.
OConnell D, Ragsdale N, Boyd D, Felder R, Carey R . Differential human renal tubular responses to dopamine type 1 receptor stimulation are determined by blood pressure status. Hypertension. 1997; 29(1 Pt 1):115-22. DOI: 10.1161/01.hyp.29.1.115. View

3.
Albrecht F, Drago J, Felder R, Printz M, Eisner G, Robillard J . Role of the D1A dopamine receptor in the pathogenesis of genetic hypertension. J Clin Invest. 1996; 97(10):2283-8. PMC: 507308. DOI: 10.1172/JCI118670. View

4.
Williams S, Addy J, Phillips 3rd J, Dai M, Kpodonu J, Afful J . Combinations of variations in multiple genes are associated with hypertension. Hypertension. 2000; 36(1):2-6. DOI: 10.1161/01.hyp.36.1.2. View

5.
Sallese M, Salvatore L, DUrbano E, SALA G, Storto M, Launey T . The G-protein-coupled receptor kinase GRK4 mediates homologous desensitization of metabotropic glutamate receptor 1. FASEB J. 2000; 14(15):2569-80. DOI: 10.1096/fj.00-0072com. View